NEURO-IMMUNO MODULATING ANALGESIC (NIMA) NANOMEDICINE PLATFORM FOR TREATMENT OF DIABETIC NEUROPATHY

The Univeristy Of Texas M.D. Anderson Cancer Center

Investigators